Sintilimab Plus Chemotherapy as Neoadjuvant and Adjuvant Treatment for Locally Advanced Oral Squamous Cell Carcinoma

NCT07371611 · clinicaltrials.gov ↗

PHASE3

Phase

RECRUITING

Status

104

Enrollment

OTHER

Sponsor class

Conditions

Locally Advanced Oral Squamous Cell Carcinoma
Oral Squamous Cell Carcinoma (OSCC)

Interventions

DRUG: Sintilimab plus nab-paclitaxel and platinum-based chemotherapy
PROCEDURE: Radical surgery combined with radiotherapy or chemoradiotherapy

Sponsor

Qunxing Li,MD